Sign In
Buy NTRA
$318.35
-3.75 (-1.16%)
At Close: Aug 10, 2026
Natera, Inc. $NTRA Stake Reduced by Allianz Asset Management GmbH
06:50am, Friday, 06'th Feb 2026
Allianz Asset Management GmbH decreased its holdings in shares of Natera, Inc. (NASDAQ: NTRA) by 2.3% in the undefined quarter, according to the company in its most recent filing with the Securities a
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
06:00am, Friday, 06'th Feb 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of EDEN, a large, multi-center prospective study design
Steven Leonard Chapman Sells 85,299 Shares of Natera (NASDAQ:NTRA) Stock
05:56am, Friday, 06'th Feb 2026
Natera, Inc. (NASDAQ: NTRA - Get Free Report) CEO Steven Leonard Chapman sold 85,299 shares of the company's stock in a transaction dated Monday, February 2nd. The stock was sold at an average price o
Michael Burkes Brophy Sells 6,939 Shares of Natera (NASDAQ:NTRA) Stock
04:40am, Friday, 06'th Feb 2026
Natera, Inc. (NASDAQ: NTRA - Get Free Report) CFO Michael Burkes Brophy sold 6,939 shares of the business's stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an aver
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test
11:30am, Tuesday, 03'rd Feb 2026
NTRA submits FDA PMA for Signatera CDx, aiming to guide bladder cancer treatment with MRD testing after positive phase 3 trial results.
Alger Weatherbie Specialized Growth Fund Q4 2025 Winners And Laggards
10:00am, Tuesday, 03'rd Feb 2026
Class A shares of the Alger Weatherbie Specialized Growth Fund outperformed the Russell 2500 Growth Index during the fourth quarter of 2025. Natera, Inc., ACADIA Pharmaceuticals Inc., and Glaukos Corp
Natera Submits Signatera™ CDx PMA to FDA
06:00am, Monday, 02'nd Feb 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the submission of its premarket approval (PMA) to the U.S. Food an
Natera, Inc. (NASDAQ:NTRA) Receives Average Rating of “Moderate Buy” from Analysts
02:00am, Monday, 02'nd Feb 2026
Natera, Inc. (NASDAQ: NTRA - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eighteen ratings firms that are covering the company, Marketbeat reports. One rese
Alger Small Cap Focus Fund Q4 2025 Portfolio Update
01:22pm, Thursday, 29'th Jan 2026
Class A shares of the Alger Small Cap Focus Fund outperformed the Russell 2000 Growth Index during the fourth quarter of 2025. Exact Sciences Corporation, Guardant Health, Inc., and Natera, Inc. were
Natera Announces Completion of Enrollment in Randomized ACES-EMB Trial in Heart Transplantation
08:00am, Wednesday, 28'th Jan 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the completion of enrollment in ACES-EMB, the first randomized-con
Prospera™ Featured in Landmark Interventional Study Advancing Lung Transplant Care
06:00am, Monday, 26'th Jan 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of a new prospective clinical trial in Transplanta
Alger Small Cap Growth Fund Q4 2025 Portfolio Update
03:54am, Monday, 26'th Jan 2026
Class A shares of the Alger Small Cap Growth Fund outperformed the Russell 2000 Growth Index during the fourth quarter of 2025. Exact Sciences Corporation, Natera, Inc., and Guardant Health, Inc. were
GDS Wealth Management Has $11.61 Million Holdings in Natera, Inc. $NTRA
05:24am, Sunday, 25'th Jan 2026
GDS Wealth Management lifted its holdings in shares of Natera, Inc. (NASDAQ: NTRA) by 11.1% during the undefined quarter, according to the company in its most recent filing with the Securities and Exc
Steven Leonard Chapman Sells 1,590 Shares of Natera (NASDAQ:NTRA) Stock
05:22am, Saturday, 24'th Jan 2026
Natera, Inc. (NASDAQ: NTRA - Get Free Report) CEO Steven Leonard Chapman sold 1,590 shares of the company's stock in a transaction that occurred on Wednesday, January 21st. The shares were sold at an
Alger Mid Cap Focus Fund Q4 2025 Portfolio Update
05:15am, Thursday, 22'nd Jan 2026
Exact Sciences Corporation, Natera, Inc., and Guardant Health, Inc. were among the top contributors to performance. Roblox Corp., Robinhood Markets, Inc., and Nebius Group were among the top detractor
